D

Differential Bio

AI-powered virtual bioprocess optimization platform

Overview

Differential Bio builds a virtual scale-up platform that blends robotic lab automation with AI to simulate microbial growth and fermentation at microliter scale. Researchers run unlimited virtual experiments that mirror large-scale stress factors, and AI models predict biomass growth, protein expression, product yield, and cell viability. The platform covers the full bioprocess pipeline with modular tools that integrate into R&D workflows and can use proprietary or historical data, enabling parameter optimization before costly scale-up. Its goal is to accelerate time to market, reduce costs, improve sustainability, and lay the groundwork for scalable biomanufacturing in the bioeconomy.

Work here?Claim your company

About Differential Bio

Simplify's Rating
Not yet rated

We're working on gathering enough insights on this company, check back soon!

Industries

Data & AnalyticsRobotics & AutomationAI & Machine LearningBiotechnology

Company Size

1-10

Company Stage

Seed

Total Funding

$2.2M

Headquarters

Feldkirchen, Germany

Founded

2024

Get referred to Differential Bio

See people who can refer or advise you

Simplify Jobs

Simplify's take

What believers are saying

  • February 25, 2026 CanBiocin case study showed +34.1% biomass yield and -27.6% media cost.
  • October 2026 CREMER launched Y-Base Blend using 50,000 combinations and 3,300 experiments.
  • November 2026 growth-media modeling and 2026 conference visibility strengthen hiring and business-development momentum.

What critics are saying

  • Differential Bio still relies on a €2 million March 2025 pre-seed, limiting runway.
  • CREMER and CanBiocin partnerships concentrate customer validation in two relationships, creating renewal risk.
  • If predictions disappoint at industrial scale, incumbents and larger automation vendors will commoditize the platform.

What makes Differential Bio unique

  • Differential Bio combines robotic fermentation experiments with AI predictions for bioprocess scale-up.
  • October 15, 2026 CREMER partnership validates commercial pull beyond pure software demos.
  • November 3, 2026 Genome-ML predicts media from genomes, extending beyond narrow process optimization.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$2.2M

Below

Industry Average

Funded Over

1 Rounds

Seed funding is usually the first official round after pre-seed, when a startup has a prototype or concept. It’s typically used to develop the product, test the market, and start building the team. Investors here are often angel investors or early-stage venture capitalists.
Seed Funding Comparison
Below Average

Industry standards

$3.3M
$2M
$2.2M
$2.3M
$3M

Benefits

  • Gym Membership
  • Stock Options

Company News

Green Queen Media
Nov 2nd, 2026
Cremer's FermBase & Differential Bio team up to develop ai-led fermentation solutions.

Cremer's FermBase & Differential Bio team up to develop ai-led fermentation solutions. By Anay Mridul Published on Nov 2, 2026 Last updated Oct 28, 2026 3 Mins Read Cremer Group's FermBase platform has extended its collaboration with Differential Bio to provide AI-led process and material solutions for novel fermentation players. A month after launching high-performing yeast blends for next-gen fermentation startups, German agrifood giant Cremer Group's FermBase platform is now expanding its offerings via a strategic collaboration with Munich-based Differential Bio. The companies have already been working together on artificial-intelligence-assisted (AI) biotech product development, jointly creating the standardised trace element yeast blends. They're now extending their partnership to provide fermentation companies with even more comprehensive support, from early-stage development through to industrial scale-up, leveraging technologies like AI, automation and data analysis. "Throughout Cremer's history, we have grown whenever we were willing to rethink our existing business and identify new opportunities at an early stage," said Cremer CEO Christian Flach. "With Differential Bio, we have found a partner that is taking entirely new approaches to raw material development with the help of artificial intelligence and robotics and brings outstanding expertise in this field." Pairing supply chain expertise with AI and automation. FermBase, launched in February this year, is described as a "competence centre and one-stop shop" for fermentation media, serving applications in the food, feed, cosmetics, and industrial sectors. It offers carbon and nitrogen sources, mineral salts, trace elements, tailor-made solutions and standardised blends, combining feedstock access with globally scalable, resilient supply chains to help companies focus on research and growth. Differential Bio, a Technical University of Munich spinout, emerged from stealth mode with €2M ($2.2M) in pre-seed funding last year. It has developed a Virtual Scale-Up platform for biomanufacturing firms, combining AI, automated lab and fermentation processes, data-driven analysis, and machine learning to accelerate and optimise biotech processes. Together, the two firms developed the trace element blend for yeast fermentation, called Y-Base Blend. They analysed more than 50,000 possible trace element combinations, which were initially narrowed down to 3,300 experiments carried out with different yeast strains. The final blend for use in bioreactors was selected from nine high-performing formulations at microlitre scale. Differential Bio contributed its expertise in automation and data-driven process development, and Cremer brought in its know-how across the raw material and supply chains. Now, though, the companies are expanding their fermentation offerings with solutions that "go far beyond" the provision of raw materials alone. Differential Bio collab part of Cremer's long-term business model. "With Differential Bio, we are advancing the transition towards bio-based production: our robotic laboratory automation generates targeted data for AI applications, while our software and AI solutions enable data-driven process development," said Differential Bio CEO Christian Spier. "Together with Cremer, we can develop faster and support the fermentation industry in making processes more efficient and scaling them more successfully." In their partnership, FermBase will serve as the central point of contact for the fermentation industry, bringing together Cremer's expertise in raw materials, product solutions, and scalable supply chains, while Differential Bio will complement these capabilities with automated development processes, data analysis, and AI-supported optimisation. For Cremer, the collaboration is part of the long-term development of its business model - in addition to providing access to raw materials and ensuring reliable supply, it plans to offer more tech-led and data-based services in the future. "For us, this partnership is therefore not only another step forward for FermBase, but also an example of how we continuously develop Cremer through innovation and strong partnerships," said Flach. The company has long been involved in planet-friendly nutrition solutions. Its Cremer Sustainable Foods division, for instance, operates a 1,000 sq m facility for alternative proteins, which can produce 1,300 tonnes of product per year. * Anay Mridul Anay is Green Queen's resident news reporter. Originally from India, he worked as a vegan food writer and editor in London, and is now travelling and reporting from across Asia. He's passionate about coffee, plant-based milk, cooking, eating, veganism, food tech, writing about all that, profiling people, and the Oxford comma. View all posts

Tech.eu
Mar 26th, 2025
Differential Bio raises €2M for scaling biomanufacturing.

Munich startup Differential Bio emerged from stealth with €2M in pre-seed funding to address biomanufacturing's scaling challenges. Their Virtual Scale-up Platform integrates advanced microbiology, lab automation, and AI to optimize and scale bioprocesses efficiently. This innovation reduces reliance on costly experiments, accelerates development, and cuts costs. The funding will enhance their platform, expand their team, and onboard new clients.

Recently Posted Jobs

Sign up to get curated job recommendations

Differential Bio is Hiring for 4 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs